White Brook Capital Partners, an investment management firm, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. White Brook Capital’s middle capitalization focused fund had a forgettable year in 2024. With the announcement of fourth-quarter earnings and positive 2025 outlook by the fund’s portfolio companies, fortunes have turned around thus far in 2025. The portfolio’s dominant theme is that it owns quality businesses in sectors that for one reason or another are out of favor. In addition, you can check the fund’s top 5 holdings to determine its best picks for 2024.
White Brook Capital Partners highlighted stocks like Rapid Micro Biosystems, Inc. (NASDAQ:RPID) in its Q4 2024 investor letter. Rapid Micro Biosystems, Inc. (NASDAQ:RPID) is a life sciences technology company. The one-month return of Rapid Micro Biosystems, Inc. (NASDAQ:RPID) was 58.89%, and its shares gained 49.02% of their value over the last 52 weeks. On January 27, 2024, Rapid Micro Biosystems, Inc. (NASDAQ:RPID) stock closed at $1.430 per share with a market capitalization of $61.54 million.
White Brook Capital Partners stated the following regarding Rapid Micro Biosystems, Inc. (NASDAQ:RPID) in its Q4 2024 investor letter:
“Rapid Micro Biosystems, Inc. (NASDAQ:RPID) was entered in early 2025. Given its small size and the focus on middle capitalization stocks in the portfolio, the Company will be a very small position in the Fund. In early January the Company preannounced fourth quarter 2024 results and announced a collaboration with a large software partner that should help the Company’s sales efforts. The stock is up over 25% this year.”
A pharmacist holding up a bottle of pharmaceutical grade product for inspection.
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 3 hedge fund portfolios held Rapid Micro Biosystems, Inc. (NASDAQ:RPID) at the end of the third quarter which was 3 in the previous quarter. In the third quarter, Rapid Micro Biosystems, Inc.’s (NASDAQ:RPID) total revenue increased 24% to $7.6 million. While we acknowledge the potential of Rapid Micro Biosystems, Inc. (NASDAQ:RPID) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
In another article, we discussed Rapid Micro Biosystems, Inc. (NASDAQ:RPID) and shared the top stock picks of billionaire Larry Robbins. In addition, please check out our hedge fund investor letters Q3 2024 page for more investor letters from hedge funds and other leading investors.
READ NEXT: Michael Burry Is Selling These Stocks and A New Dawn Is Coming to US Stocks.
Disclosure: None. This article is originally published at Insider Monkey.